Amoxicillin And Clavulanate Potassium Suspension
Product Images NDC 0143-9853
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 0143-9853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Clavulanate Structure (Amoxicillin And Clavulanate Potassium For Oral Sus 2)
Amoxicillin And Clavulanate Potassium For Ora Suspension Usp75 mL (Amoxicillin And Clavulanate Potassium For Oral Sus 3)
This appears to be a combination medication for oral suspension, containing 600 mg Amoxicillin (as trihydrate) and 429 mg of Clavulanate potassium, sold by Westward Pharmaceuticals Corp. The recommended dosage is to administer every 12 hours. The medication should be shaken well before use and kept out of children's reach. The solution must be used within 10 days of opening.*
Amoxicillin And Clavulanate Potassium For Oral Suspension Usp125 mL (Amoxicillin And Clavulanate Potassium For Oral Sus 4)
Amoxicillin And Clavulanate Potassium For Oral Suspension Usp200 mL (Amoxicillin And Clavulanate Potassium For Oral Sus 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.